Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
ProHealth Longevity is a nutritional supplement company specializing in products designed to support healthy aging and longevity. Founded in 1988, the company has evolved from focusing on chronic fatigue and fibromyalgia to becoming a leader in the NAD+ boosting market, offering high-purity Nicotinamide Mononucleotide (NMN) and Nicotinamide Riboside (NR). They emphasize third-party testing and pharmaceutical-grade ingredients to ensure product potency and safety. ProHealth collaborates with researchers and provides a wide range of supplements targeting cellular health, mitochondrial function, and metabolic support. The company is recognized for its commitment to transparency and quality in the nutraceutical industry. Their products are frequently used in clinical trials to investigate the effects of NAD+ precursors on human health.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on ProHealth Longevity.